FDA.reportPublic FDA data

treprostinil 26.5 MCG Inhalation Powder

RxCUI
2714659
RxNorm name
treprostinil 26.5 MCG Inhalation Powder
Display name
treprostinil 26.5 MCG Inhalation Powder
Full name
treprostinil 26.5 MCG Inhalation Powder
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
e8f6d534-115c-440e-bdbb-b443a29bb468treprostinil 26.5 MCG Inhalation PowderPSN3These highlights do not include all the information needed to use YUTREPIA™ safely and effectively. See full prescribing information for YUTREPIA™ . YUTREPIA™ (treprostinil) inhalation powder, for oral inhalation Initial U.S. Approval: 200220250908
e8f6d534-115c-440e-bdbb-b443a29bb468treprostinil 26.5 MCG Inhalation PowderSY3These highlights do not include all the information needed to use YUTREPIA™ safely and effectively. See full prescribing information for YUTREPIA™ . YUTREPIA™ (treprostinil) inhalation powder, for oral inhalation Initial U.S. Approval: 200220250908
e8f6d534-115c-440e-bdbb-b443a29bb468treprostinil 26.5 MCG (equivalent to treprostinil sodium 28 MCG) Inhalation PowderSY3These highlights do not include all the information needed to use YUTREPIA™ safely and effectively. See full prescribing information for YUTREPIA™ . YUTREPIA™ (treprostinil) inhalation powder, for oral inhalation Initial U.S. Approval: 200220250908
e8f6d534-115c-440e-bdbb-b443a29bb468treprostinil 0.0265 MG Inhalation PowderSCD3These highlights do not include all the information needed to use YUTREPIA™ safely and effectively. See full prescribing information for YUTREPIA™ . YUTREPIA™ (treprostinil) inhalation powder, for oral inhalation Initial U.S. Approval: 200220250908